MedPath

Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

Not Applicable
Completed
Conditions
Thromboembolism
Registration Number
NCT00024297
Lead Sponsor
Cancer Research Campaign Clinical Trials Centre
Brief Summary

RATIONALE: Warfarin may be effective in preventing the formation of blood clots in patients with central venous catheters.

PURPOSE: Randomized clinical trial to study the effectiveness of warfarin in preventing blood clots in cancer patients who have central venous catheters.

Detailed Description

OBJECTIVES:

* Determine the utility of warfarin in reducing thrombosis rates in cancer patients with central venous catheters.

* Compare the thrombosis rates in patients treated with different warfarin dosing schedules.

* Compare the adverse events and survival of patients receiving or not receiving this drug.

OUTLINE: This is a randomized, multicenter study. Patients are stratified according to sclerosant potential of cytotoxic regimen (low vs high), site of placement of catheter (peripheral vs central), and duration of drug administration (brief infusion (under 24 hours) vs prolonged infusion (24 hours and over)). Patients are randomized to 1 of 3 arms.

* Arm I: Patients receive no warfarin.

* Arm II: Patients receive oral warfarin daily beginning 3 days before placement of central venous catheter (CVC) and continuing until CVC is removed or thrombosis occurs.

* Arm III: Patients receive oral warfarin as in arm II, with dose adjustment after CVC placement to achieve and maintain INR level.

Patients are followed at 12 months.

PROJECTED ACCRUAL: A total of 1,400 patients (400 in arm I, 700 in arm II, and 300 in arm III) will be accrued for this study within 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (38)

Queen Elizabeth Hospital at University of Birmingham

🇬🇧

Birmingham, England, United Kingdom

City Hospital - Birmingham

🇬🇧

Birmingham, England, United Kingdom

Birmingham Heartlands and Solihull NHS Trust -Teaching

🇬🇧

Birmingham, England, United Kingdom

Bristol Haematology and Oncology Centre

🇬🇧

Bristol, England, United Kingdom

Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust

🇬🇧

Cambridge, England, United Kingdom

Cumberland Infirmary

🇬🇧

Carlisle, England, United Kingdom

Cheltenham General Hospital

🇬🇧

Cheltenham, England, United Kingdom

Essex County Hospital

🇬🇧

Colchester, England, United Kingdom

Royal Devon and Exeter Hospital

🇬🇧

Exeter, England, United Kingdom

Diana Princess of Wales Hospital

🇬🇧

Grimsby, England, United Kingdom

Scroll for more (28 remaining)
Queen Elizabeth Hospital at University of Birmingham
🇬🇧Birmingham, England, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.